Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
15.02
+0.61 (4.23%)
At close: Nov 7, 2025, 4:00 PM EST
15.07
+0.05 (0.33%)
After-hours: Nov 7, 2025, 7:20 PM EST
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $2.2 billion as of November 7, 2025. Its market cap has decreased by -41.10% in one year.
Market Cap
2.20B
Enterprise Value
1.37B
1-Year Change
-41.10%
Ranking
Category
Stock Price
$15.02
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.20B, an increase of 16.54%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 2.20B | -25.02% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |